Excellence in science communication
Out now: paper in EMBO reports and MRC Blog about educational resources developed by Prof Ian Chambers and Emma Kemp.
New CRM - Genzyme collaboration
To identify therapeutic candidates capable of promoting remyelination and reduce neurodegeneration.
Funding for cell therapy trial
CRM Prof Stuart Forbes said: “If successful, we hope this could offer a new way to tackle liver cirrhosis.”
Cited2 regulator of ES cell functions
Prof Kamil Kranc said: “This study implies that Cited2 is a critical and universal master regulator of stem cell functions, an essential step in the development of new stem cell treatments and cancer therapies.”